World Orphan Drug Congress 2020

Memo

The World Orphan Drug Congress is an award-winning event with an exhibition that has grown to become the largest and most established orphan drugs And rare diseases meeting of its kind across the globe. Now in its 11th annual edition, the World Orphan Drug Congress Europe, together with the co-located Cell And Gene Therapy Congress, will continue to bring experts from the whole value chain under one roof, where you get to meet decision makers in the areas that are most applicable for your business offering. With 700+ attendees and 200 speakers from all around the world, there will be countless opportunities to discuss solutions to challenges around the political, commercial and scientific issues focusing on:- manufacturing- clinical trials- strategy- regulation And policy- Market Access And Pricing- Science And Strategy- Pitch And Partner- Precision Medicine. URLs:Brochure: https://go.evvnt.com/600890-0?pid=5569Booking: https://go.evvnt.com/600890-3?pid=5569 Speakers: Yann Le Cam, CEO, EURORDIS, Rick Thompson, CEO, Findacure, Durhane Wong-Rieger, President And CEO, Canadian Organization for Rare Disorders, Dr Segolene Ayme, Founder of Orphanet, Emeritus Research Director, INSERM, Steve Groft, Senior Advisor to Director, NCATS, NIH, Dr Josep Torrent-Farnell, Former Head of the Medicines Divison, CatSalut, Alastair Kent, Former Director, Genetic Alliance UK, Sheela Upadhyaya, Former Associate Director Highly Specialised Technologies, NICE, Dr Bruno Sepodes, Chair of COMP, EMA, Dr Pedro Franco, Former Scientific Administrator, EMA, Josie Godfrey, Former Associate Director, NICE, Anna Bucsics, Project Advisor, MoCA, Dr Alexander Natz, Secretary General, EUCOPE, Dr Diego Ardigo, IRDiRC Chair And R&D Rare Diseases Unit Head, Chiesi Group, Professor Michael Linden, Former VP Gene Therapy And Head, GMI, Pfizer, Wills Hughes-Wilson, Head of Patient Access And Commercial Planning, Mereo BioPharma, Dr Carlo Incerti, SVP, Former Head of Global Medical Affairs, CMO, Genzyme, Dr Mathew Pletcher, Head of Rare Disease Discovery, Roche, Dr M Ken Kengatharan, Managing Director, Atheneos, Dr Birgitte Volck, President, R&D, AVROBIO Date And Time:On Monday November 02, 2020 at 8:00 am (ends Thursday November 05, 2020 at 6:00 pm) Venue Details:Meliá Sitges, 38 Carrer de Joan Salvat Papasseit, Sitges, Catalunya, 08870, Spain